ID

21522

Description

Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT00300729

Link

https://clinicaltrials.gov/show/NCT00300729

Keywords

Versions (1)
  1. 4/25/17 4/25/17 -
Uploaded on

April 25, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-Small Cell Lung Cancer NCT00300729

English

Eligibility Non-Small Cell Lung Cancer NCT00300729

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed non-small cell lung cancer (nsclc).
Description

Non-small cell lung cancer

Data type

boolean

Alias
UMLS CUI [1]
C0007131
age at least 18 years. no upper age limit.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
disease stage iiib or iv.
Description

Tumor Stage

Data type

boolean

Alias
UMLS CUI [1]
C1300072
performance status (who) 0-2
Description

Performance Status

Data type

boolean

Alias
UMLS CUI [1]
C1518965
treatment with curative intent is not possible
Description

Curative Intention

Data type

boolean

Alias
UMLS CUI [1]
C1276305
no prior chemotherapy for the present disease
Description

Prior chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C1514457
planned treatment is palliative chemotherapy
Description

Palliative Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C4272534
wbc count at least 3.0, platelet count at least 100
Description

WBC, Platelets

Data type

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0005821
bilirubin < 1.5 * upper reference limit (url), asat and alat < 3 * url (<5 in case of liver metastases)
Description

Bilirubin, ASAT, ALAT

Data type

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
calculated creatinine clearance at least 40 mg/ml
Description

Creatinine Clearance

Data type

boolean

Alias
UMLS CUI [1]
C0373595
informed oral and written consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
regular use of nsaid (except asa at a dose of 50-100 mg daily)
Description

NSAID Use

Data type

boolean

Alias
UMLS CUI [1,1]
C0003211
UMLS CUI [1,2]
C1524063
active duodenal ulcer, ongoing gastrointestinal bleeding or inflammatory bowel disease
Description

Duodenal ulcer, gastrointestinal bleeding or inflammatory bowel disease

Data type

boolean

Alias
UMLS CUI [1]
C0013295
UMLS CUI [2]
C0017181
UMLS CUI [3]
C0021390
serious heart failure or serious liver disease
Description

Heart failure or Liver disease

Data type

boolean

Alias
UMLS CUI [1]
C0018801
UMLS CUI [2]
C0023895
hypersensitivity to sulfonamides
Description

Hypersensitivity to sulfonamides

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0038760
pregnancy
Description

Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
lactation
Description

Lactation

Data type

boolean

Alias
UMLS CUI [1]
C0006147
Back to the top of the page

Similar models

Eligibility Non-Small Cell Lung Cancer NCT00300729

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-small cell lung cancer
Item
histologically or cytologically confirmed non-small cell lung cancer (nsclc).
boolean
C0007131 (UMLS CUI [1])
Age
Item
age at least 18 years. no upper age limit.
boolean
C0001779 (UMLS CUI [1])
Tumor Stage
Item
disease stage iiib or iv.
boolean
C1300072 (UMLS CUI [1])
Performance Status
Item
performance status (who) 0-2
boolean
C1518965 (UMLS CUI [1])
Curative Intention
Item
treatment with curative intent is not possible
boolean
C1276305 (UMLS CUI [1])
Prior chemotherapy
Item
no prior chemotherapy for the present disease
boolean
C1514457 (UMLS CUI [1])
Palliative Chemotherapy
Item
planned treatment is palliative chemotherapy
boolean
C4272534 (UMLS CUI [1])
WBC, Platelets
Item
wbc count at least 3.0, platelet count at least 100
boolean
C0023508 (UMLS CUI [1])
C0005821 (UMLS CUI [2])
Bilirubin, ASAT, ALAT
Item
bilirubin < 1.5 * upper reference limit (url), asat and alat < 3 * url (<5 in case of liver metastases)
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
Creatinine Clearance
Item
calculated creatinine clearance at least 40 mg/ml
boolean
C0373595 (UMLS CUI [1])
Informed Consent
Item
informed oral and written consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
NSAID Use
Item
regular use of nsaid (except asa at a dose of 50-100 mg daily)
boolean
C0003211 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
Duodenal ulcer, gastrointestinal bleeding or inflammatory bowel disease
Item
active duodenal ulcer, ongoing gastrointestinal bleeding or inflammatory bowel disease
boolean
C0013295 (UMLS CUI [1])
C0017181 (UMLS CUI [2])
C0021390 (UMLS CUI [3])
Heart failure or Liver disease
Item
serious heart failure or serious liver disease
boolean
C0018801 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
Hypersensitivity to sulfonamides
Item
hypersensitivity to sulfonamides
boolean
C0020517 (UMLS CUI [1,1])
C0038760 (UMLS CUI [1,2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Lactation
Item
lactation
boolean
C0006147 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial